Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Venture financing activity hit the ground running in 2018 after a bumper haul of mega-raises brought the total deal value for January close to $1bn.
The winter chill has not put a freeze on venture financing activity, with January's total deal value leaping three times higher than levels seen in December and a year ago.
Medtech Insight's VC financing deal tracker recorded 31 transactions in January, and from the 30 deals that disclosed financial details, $962.5m was raised in total, making it the most successful January over the last five years.
These impressive takings – a three-fold jump from the $318.4m raised in December and $343.5m in January 2017 – got a big helping hand from the bumper harvest of big-buck fundraisings, with five deals raising over $50m.
This is the highest number of $50m-plus deals ever recorded byMedtech Insightover the five-year period of 2014-2018 and includes a nine-figure $200m round by SomaLogic. (See Table 1)
Table 1: Top 5 Medtech VC Deals, January 2018
|
Ranking |
Company |
Based in |
Product/ Therapy sector |
Amount raised |
Financing round |
Total investment |
|
1 |
SomaLogic |
CO, US |
IVD |
$200m |
Undisclosed |
Undisclosed |
|
2 |
Millipede |
CA, US |
Cardiology |
$90m |
Undisclosed |
Undisclosed |
|
3 |
Personal Genome Diagnostics |
MD, US |
IVD |
$75m |
Series B |
Undisclosed |
|
4 |
Metavention |
MI, US |
Neuromodulation |
$65m |
Series C |
Undisclosed |
|
5 |
DNAnexus |
CA, US |
Bioinformatics |
$58m |
Undisclosed |
Undisclosed |
Source: Medtech Insight VC deal tracker
Boulder, Colorado-based SomaLogic developed the SOMAscanassay for highly multiplexed protein measurement. It can measure around 5,000 proteins in a small sample of serum, plasma, or cerebrospinal fluid. This biomarker analysis can be applied to clinical diagnostics or drug discovery and development applications. It is currently using its proteomics technology to build a biomarker database; the company has analysed over 150,000 samples across more than 50 diseases and plans to add one million more samples by the end of 2020.
Signalling the continued interest from Chinese investors in foreign health care assets, one of SomaLogic's key investor in the $200m funding round is Nan Fung Life Sciences, which invested in hearing aid-developer Eargoin October last year. The other significant investor in this round was Madryn Asset Management.
Molecular diagnostics look likely to continue to be a hot spot for venture investors, with two other companies in this area – Personal Genome Diagnostics and DNAnexus – making the top five biggest VC deals. But the second biggest deal came from cardiology, which is typically follows IVD as the most popular product/therapy sector for investment.
Millipede's $90m equity investment comes from Boston Scientific, which also signed an option to acquire the California firm. The stake in Millipede gives Boston Scientific an asset in the "next big thing" in structural heart, mitral valve repair, and puts it in the race among the other transcatheter heart therapy giants like Edwards and Medtronic, who are already some distance ahead. (Also see "Boston Scientific Hooks In Millipede, But Still Trailing Behind In Mitral Valve Race" - Medtech Insight, 25 Jan, 2018.)
Looking at the most popular areas for investment in January, aside from the usual suspects IVD and cardiology taking top two spots, neuromodulation came third, with four transactions. Indeed, a neuromodulation company, Metavention, made it to the top 5 biggest deals of the month with a $65m series C. Metavention'sMetabolic Neuromodulation Therapyuses a transcather technology to modulate the sympathetic nervous system to control blood glucose levels in Type 2 diabetes patients.
Investors are increasingly interested in neuromodulation, as adoption of bioelectronic medicine technologies gain wider acceptance and better understanding by the clinical community.
Other potential hot areas of investment to look out for, based on 2017 trends, are therapies for chronic diseases such as respiratory disorders and sleep disorders, as well as technologies for better diabetes management.
The total takings for 2017 surpassed the previous years, and with 2018 having had a flying start, the year's venture financing climate might continue to soar in the months to come.
Biomedtracker: follow the drug development process
03 Apr 2017
Learn why pharmaceutical, biotech, and investment companies rely on BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.
Biomedtracker: follow the drug development process
What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.
Topics Drug development landscape
Scrip: industry news and insights
By Lucie Ellis
In an exclusive interview, Sanofi's head of oncology development Joanne Lager explains how the French big pharma could make a comeback in cancer this year and highlights its immunotherapy combination opportunities.
Topics Cancer
無料トライアルのお申込み
お問い合わせ先
ご質問等ございましたらお気軽にご連絡ください。
お問合せフォームまたはEメールでもご質問を承っています（日本オフィス営業時間：平日9時～18時）
レポートストア
オンラインショップのレポートストアでは、常時1000以上の市場分析レポートをご提供しています。
お探しの情報が見つからない場合は、左記のお問い合わせ先までお気軽にご連絡ください。
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Looking for more products Product Finder
